SCHEMBL16330760

SCHEMBL16330760

CNC(C(=O)Nc1ncnc2c1c(C#N)cn2[C@@H]1O[C@H](CO)C(OC(C)=O)[C@@H]1OC(C)=O)C(C)C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HIF1A Q16665 2/20 0.49
▸ PAX8 Q06710 1/20 0.49
▸ PRKAB2 O43741 1/20 0.38
▸ PRKAG1 P54619 1/20 0.38
▸ PRKAA2 P54646 1/20 0.38
▸ PRKAA1 Q13131 1/20 0.38
▸ PRKAG3 Q9UGI9 1/20 0.38
▸ PRKAG2 Q9UGJ0 1/20 0.38
▸ PRKAB1 Q9Y478 1/20 0.38
▸ ADK P55263 7/20 0.38
▸ TMEM97 Q5BJF2 3/20 0.36
▸ SIGMAR1 Q99720 2/20 0.36
▸ DOT1L Q8TEK3 3/20 0.36
▸ PRMT5 O14744 1/20 0.36
▸ PRMT3 O60678 1/20 0.36
▸ DNMT1 P26358 1/20 0.36
▸ EHMT2 Q96KQ7 1/20 0.36
▸ PRMT6 Q96LA8 1/20 0.34
▸ TP53 P04637 2/20 0.34
▸ ALDH1A1 P00352 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16330690 0.89 HIF1A (0.48) HIF1APAX8PRKAB2PRKAG1PRKAA2
SCHEMBL16330727 0.88 HIF1A (0.46) HIF1APAX8PRKAB2PRKAG1PRKAA2
SCHEMBL16330693 0.88 HIF1A (0.53) HIF1APAX8ADKTMEM97SIGMAR1
SCHEMBL16330759 0.88 HIF1A (0.41) HIF1APAX8PRKAB2PRKAG1PRKAA2
SCHEMBL16330723 0.86 HIF1A (0.63) HIF1APAX8ADKTMEM97SIGMAR1
SCHEMBL16330687 0.84 HIF1A (0.50) HIF1APAX8PRKAB2PRKAG1PRKAA2
SCHEMBL16330763 0.81 HIF1A (0.51) HIF1APAX8ADKTMEM97SIGMAR1
SCHEMBL16330758 0.81 HIF1A (0.40) HIF1APAX8PRKAB2PRKAG1PRKAA2
SCHEMBL16330701 0.80 ADK (0.46) HIF1APAX8ADKPRMT5
SCHEMBL16330724 0.80 HIF1A (0.60) HIF1APAX8ADKTMEM97SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130018010-A1 POLYMERIC CONJUGATES OF ADENINE NUCLEOSIDE ANALOGS ENZON PHARMACEUTICALS, INC. (US) 2013-01-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130018010-A1 POLYMERIC CONJUGATES OF ADENINE NUCLEOSIDE ANALOGS VEGFA, MKI67, PCNA HIF1A 922/4885PAX8 3693/4885PRKAB2 1890/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback